Previous Article | Next Article 
J Virol, May 1998, p. 4281-4287, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
fus-1, a pH Shift Mutant of Semliki Forest Virus, Acts
by Altering Spike Subunit Interactions via a Mutation in the E2
Subunit
Sallie
Glomb-Reinmund and
Margaret
Kielian*
Department of Cell Biology, Albert Einstein
College of Medicine, Bronx, New York 10461
Received 22 October 1997/Accepted 23 January 1998
 |
ABSTRACT |
Semliki Forest virus (SFV), an enveloped alphavirus, is a
well-characterized paradigm for viruses that infect cells via endocytic uptake and low-pH-triggered fusion. The SFV spike protein is composed of a dimer of E1 and E2 transmembrane subunits, which dissociate upon
exposure to low pH, liberating E2 and the fusogenic E1 subunit to
undergo independent conformational changes. SFV fusion and infection
are blocked by agents such as ammonium chloride, which act by raising
the pH in the endosome and inhibiting the low-pH-induced conformational
changes in the SFV spike protein. We have previously isolated an SFV
mutant, fus-1, that requires more acidic pH to trigger its
fusion activity and is therefore more sensitive to inhibition by
ammonium chloride. The acid shift in the fusion activity of
fus-1 was here shown to be due to a more acidic pH threshold for the initial dissociation of the fus-1 spike
dimer, thereby resulting in a more acidic pH requirement for the
subsequent conformational changes in both fus-1 E1 and
fus-1 E2. Sequence analysis demonstrated that the
fus-1 phenotype was due to a mutation in the E2 spike
subunit, threonine 12 to isoleucine. fus-1 revertants that
have regained the parental fusion phenotype and ammonium chloride
sensitivity were shown to have also regained E2 threonine 12. Our
results identify a region of the SFV E2 spike protein subunit that
regulates the pH dependence of E1-catalyzed fusion by controlling the
dissociation of the E1/E2 dimer.
 |
INTRODUCTION |
Virus fusion proteins have evolved
to keep their membrane fusion activities inactive on the surface of the
virus membrane until specifically triggered by the conditions of
infecting a host cell. In the case of viruses that fuse at the plasma
membrane, fusion can be triggered by receptor binding (1,
11) and may require additional molecules that function as
coreceptors, as does human immunodeficiency virus type 1 (2,
7). For those viruses that use the endocytic pathway and low pH
to infect cells, fusion is specifically triggered by the mildly acidic
pH within endocytic vesicles (1, 11). A well-characterized
example of such a low-pH-dependent virus is the enveloped alphavirus
Semliki Forest virus (SFV) (reviewed in references
16 and 30). SFV fusion is
catalyzed by the virus spike protein, triggered by an endosomal pH of
6.2, and blocked by agents such as NH4Cl or monensin, which act by raising the pH within endosomes above the critical threshold required to trigger virus-membrane fusion.
The SFV spike protein is composed of trimers (E1/E2/E3)3,
containing a dimer of two transmembrane subunits, E1 and E2, of about
50 kDa, and an associated peripheral polypeptide, E3, of about 10 kDa.
E3 and E2 are synthesized as a precursor, p62, which is
posttranslationally processed after a tetrabasic cleavage site, probably in the trans-Golgi network (5). E1 is the
fusion-active spike protein subunit, contains the putative fusion
peptide between amino acids 79 and 97 (8, 19, 23), and binds
specifically to membranes upon acid-pH treatment (22). E1
forms a tight but nonconvalent dimer with p62 in the rough endoplasmic
reticulum and is transported to the plasma membrane and packaged into
the virus particle in association with p62/E2.
Exposure to acid pH in vitro or within the endosome triggers a defined
series of conformational changes within the SFV spike protein
(see references 9 and 16 for
reviews). The dimeric interaction between E2 and E1 is
disrupted, resulting in the loss of coimmunoprecipitation and
cosedimentation on sucrose gradients. E2 becomes trypsin sensitive and
exposes new antigenic epitopes, and E1 exposes new antigenic
epitopes, becomes trypsin resistant, forms a stable E1 homotrimer,
and associates with the target membrane. The E1 homotrimer appears to
be critical for fusion, as a mutation within the fusion peptide,
glycine 91 to aspartate, prevents E1 homotrimer formation and also
blocks fusion and infection (19).
An SFV mutant, fus-1, with a lower pH threshold for membrane
fusion was isolated by selecting for viruses resistant to in vitro
fusion with RNase-filled liposomes (20). Unlike the
wild-type (wt) virus pH threshold of ~6.2, fus-1 requires
treatment below ~pH 5.5 to trigger fusion (20). As
predicted from its more acidic pH dependence, fusion of
fus-1 occurs within late endosomes, which have a more acidic
lumenal pH than early endosomes (21, 29), and
fus-1 infection is more sensitive than wt to inhibition by weak bases that raise the pH of endosomes (20).
Studies of the pH-dependent spike protein conformational changes in
fus-1 revealed an interesting paradox, in that
fus-1's lower pH threshold of fusion did not correlate with
a lower pH threshold for the conformational change in a single subunit.
The E2 subunit of fus-1 has a lower pH threshold than wt for
the binding of acid-specific monoclonal antibodies (MAbs)
(18) and for conversion to trypsin sensitivity
(17). Surprisingly, assays of fus-1 E1 conformational changes suggested that a more acidic pH was also required to trigger its acid-specific MAb binding (18) and
conversion to trypsin resistance (29). Thus, it was unclear
which subunit conferred the fus-1 phenotype, or if a double
mutation could be involved.
Recently, in vitro mutagenesis of the SFV p62 cleavage site was used to
block the processing of p62 to E2 and E3. These studies indicated that
cleavage is important in the control of the SFV fusion reaction
(13, 25, 26, 28). Viruses containing uncleaved p62 are not
infectious, and the p62/E1 form of the spike protein requires much
lower pH, ~5.0, to trigger fusion (28). This lower pH
threshold is due to the fact that the dissociation of the E1/p62 dimer
requires a considerably lower pH than does the dissociation of the
E1/E2 dimer normally found in the virus particle (28, 33).
Thus, dimer dissociation seems a prerequisite for the subsequent conformational changes in E1 that lead to fusion and infection.
These findings on the p62 mutants suggested to us that the lower pH
threshold of fus-1 E1 and E2 conformational changes could be
due to alterations in fus-1 dimer interactions. Synthesis
and processing of the fus-1 spike protein appear normal, and
the assembled virus contains E2 (20). It was possible,
however, that the dissociation of the fus-1 E1/E2 dimer
interaction was nonetheless shifted to a more acidic pH. Such a dimer
alteration could cause the lower pH thresholds of the E1 and E2
conformational changes and result in a more acidic pH threshold for
fusion.
A goal of this study was to determine the molecular mechanism
responsible for the lower pH thresholds of the fus-1 E1 and E2 conformational changes. Amino acid sequence differences had been
reported between the prototype wt SFV strain and a plaque-purified strain derived from it (here referred to as S1J) (15). S1J
was the direct parent virus to both fus-1 and a number of
previously reported temperature-sensitive (ts) mutants. To map the
fus-1 mutation, we expressed the fus-1 structural
proteins in the context of the wt virus infectious clone (wt/ic). We
then used this virus chimera, fus-1/ic, together with
fus-1, wt virus, and the S1J parent virus to analyze
acid-induced spike protein conformational changes and dimer
dissociation and to determine the amino acid sequence of the structural
proteins.
(Data in this report are from a thesis submitted by Sallie
Glomb-Reinmund in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Sue Golding Graduate Division of
Medical Sciences, Albert Einstein College of Medicine, Yeshiva University.)
 |
MATERIALS AND METHODS |
Viruses.
Our wt virus stock was previously plaque purified
from prototype wt virus obtained from the Department of Virology at the University of Helsinki and is referred to as wt in this study and
others (20, 32). The parent virus to fus-1 is a
plaque-purified virus stock derived at the University of Helsinki and
is here referred to as S1J (15). fus-1 was
isolated from S1J by mutagenesis with nitrosoguanidine and selection
for resistance to fusion with RNase-filled liposomes at pH 5.5 (20). The fus-1 revertants R43 and R46 were
selected for resistance to inhibition by NH4Cl, and were
shown to have fusion and entry properties similar to those of the
parent virus (21).
Virus stocks were prepared by propagation in BHK cells at low
multiplicity of infection (20).
[35S]methionine/cysteine-labeled virus was prepared in
BHK cells and purified by banding on a discontinuous sucrose gradient,
all as previously described (20).
Virus infectious clones.
RNA from fus-1 virus was
isolated, cDNA was synthesized, and a 5-kb
SalI/HindIII fragment encoding the
fus-1 structural proteins was cloned into the plasmid pZ152
to give pfus-1sp, all as previously described for wt virus
(23). To confirm the fus-1 phenotype and permit
future mapping, the fus-1 structural protein coding sequences were subcloned into the pSP6-SFV-4 wt/ic (24) by
using the following strategy. The fus-1 parent virus S1J was
reported to have a sequence change of E2 His170 to Arg, which would be predicted to ablate an NdeI site, leaving a unique
NdeI site at the 3' end of E1 (31). The loss of
the E2 NdeI site in pfus-1sp was confirmed by
restriction digestion (data not shown). pfus-1sp was
digested to completion with BglII and NdeI, and
the 4,318-bp fragment encoding the fus-1 structural proteins
was purified. This was ligated with the 9,970-bp
BglII/NdeI fragment from wt/ic to give
fus-1/ic, which contained nucleotides 6716 to 11034 derived from the fus-1 virus. All bacterial growth steps were
performed at 30°C to minimize rearrangement of the infectious clone
(32). Virus stocks derived from the wt/ic and
fus-1/ic plasmids were prepared by RNA transcription and
electroporation of BHK cells as previously described (6, 24)
and used to prepare [35S]methionine/cysteine labeled
virus as described above.
DNA sequence analysis.
All DNA sequencing was performed by
DyeDioxy-Terminator cycle sequencing in the Einstein sequencing
facility, using an automated DNA sequencer (Applied Biosystems). To
sequence from virus RNA, virus was grown in one 75-cm2
flask of BHK cells and pelleted for 1 h at 40,000 rpm in an SW41 rotor at 4°C. Viral RNA was isolated, reverse transcribed, and amplified by PCR, using either Vent (New England Biolabs, Inc., Beverly, Mass.) or Pfu (Stratagene, La Jolla, Calif.)
polymerase as previously described (19, 32) and as
recommended by the manufacturers. The amplified DNA was purified for
sequencing by using a QIAquick kit (Qiagen Inc., Chatsworth, Calif.).
Sequence analysis of fus-1 and fus-1/ic revealed
nine single base changes compared to the sequence of the wt/ic obtained
from Peter Liljeström (24). There were three silent
mutations, which were at positions proline 22 in capsid (CCT
CCC),
phenylalanine 258 in E2 (TTC
TTT), and cysteine 96 in E1 (TGC
TGT).
The remaining mutations are summarized in Fig. 7. Note also that
position 323 of E1 was an aspartic acid in both our wt virus and wt/ic,
in agreement with our previous analysis (32), and that E2
position 162 was a lysine in our wt virus and wt/ic, while these
positions in the original SFV sequence were reported as asparagine and
glutamic acid, respectively (8).
Virus RNA synthesis assay.
BHK cells were grown in 24-well
trays and incubated with the indicated concentrations of
NH4Cl for 15 min at 37°C. Cells were then infected with
virus at a multiplicity of infection of ~1 PFU/cell in the presence
of the indicated concentrations of NH4Cl for 90 min (termed
the virus entry step), treated for 30 min at 37°C with 2 µg of
actinomycin D (ACD) per ml and 15 mM NH4Cl to inhibit
cellular RNA synthesis and secondary virus infection, and labeled with
[3H]uridine in this medium for 3.5 h. To harvest,
cells were washed on ice with phosphate-buffered saline (PBS), fixed
with 1 ml of ice-cold 10% trichloroacetic acid (TCA) for 60 min,
washed with 0.5 ml of cold 5% TCA, and lysed at room temperature with
0.5 ml of 0.1 M KOH for 30 min, and the radioactivity in the lysates was determined by liquid scintillation counting. Each experiment included control cells infected in the absence of NH4Cl
during the virus entry step and then labeled as described above.
Triplicate samples were run, and [3H]uridine
incorporation was calculated as percent incorporation compared to
control cells.
Analysis of low-pH-dependent conformational changes in virus
spike proteins.
The overall method to assess conformational
changes in the virus spike protein involved treating
[35S]methionine/cysteine-labeled virus at the indicated
pH in the presence of 1 mM liposome target membranes
(cholesterol/phospholipid ratio of 1:2) as indicated. Liposomes were
prepared from purified phospholipids and cholesterol as previously
published (22). The virus mixture was then neutralized, and
conformational changes were evaluated. The pH dependence of E1/E2 dimer
dissociation was monitored by solubilizing virus samples with 1.0 to
0.2% Nonidet P-40 (NP-40) prior to neutralization and sedimenting them
on 5 to 20% (wt/wt) sucrose gradients containing 0.1% NP-40 in a
Beckman SW41 rotor at 39,000 rpm for 22 h at 4°C (6,
33). The exposure of acid conformation-specific epitopes was
determined by immunoprecipitation with previously characterized acid
conformation-specific MAbs (18). Formation of the E1
homotrimer was evaluated by incubating samples in sodium dodecyl
sulfate (SDS) gel sample buffer for 3 min at 30°C and then analyzing
them by SDS-polyacrylamide gel electrophoresis (PAGE) (19,
35). E1 conversion to trypsin resistance was assayed by digestion
of samples with 200 µg of tosylsulfonyl phenylalanyl chloromethyl
ketone-trypsin per ml in 1% Triton X-100 in PBS containing
Ca2+ and Mg2+ (PBS2+) for 10 min at
37°C, followed by TCA precipitation and SDS-PAGE analysis (19,
29). Quantitation of SDS-gel assays was performed by
phosphorimaging and ImageQuant 3.3 software (Molecular Dynamics, Sunnyvale, Calif.).
Analysis of low-pH-dependent conformational changes in virus
spike protein ectodomains.
Soluble monomeric ectodomain fragments
of the E1 and E2 subunits, termed E1* and E2*, were prepared by
digestion with proteinase K in Triton X-114 and purified by phase
separation and concanavalin A chromatography as previously described
(17, 22). Samples were pH treated in the presence of 1 mM
liposomes (cholesterol/phospholipid ratio of 1:1), and conformational
changes were evaluated by immunoprecipitation with acid
conformation-specific MAbs and by solubilization in SDS-gel sample
buffer for 3 min at 30°C and SDS-PAGE to visualize formation of the
E1* homotrimer (22).
 |
RESULTS |
fus-1 cloning and infectious clone construction.
Little was known about potential amino acid sequence differences
between fus-1 and the wt and S1J strains except that
fus-1 had no alterations in the sequence of the putative
fusion peptide on the E1 subunit (23). We chose to
substitute the cloned fus-1 structural proteins into wt/ic,
reasoning that by this strategy we would obtain a clone that should
express the fus-1 phenotype and enable further mapping if
necessary. cDNA was prepared from fus-1 viral RNA, and an
~4-kb fragment encoding the fus-1 structural proteins was
subcloned into wt/ic to generate fus-1/ic. This virus chimera contains the C-terminal third of the fus-1
nonstructural protein 4, the complete fus-1 capsid, E3, E2,
and 6K sequences, and the sequence of fus-1 E1 from the
amino terminus to a point about 24 residues above the C-terminal
transmembrane domain. This clone was used to produce
fus-1/ic virus stock and radiolabeled virus, which were used
to establish fusion phenotype and characterize spike protein
conformational changes.
Spike protein conformational changes in fus-1 and
fus-1/ic.
Our laboratory and others have isolated MAbs
that are specific for the acid conformation of the E1 or E2 spike
subunits (18, 35). Exposure of both the E1 and E2
acid-induced epitopes is shifted to ~pH 5.3 for fus-1,
compared to the wt threshold of pH 6.2 (18). Kinetic studies
of wt virus show the E2 conversion happens postfusion whereas E1
reactivity occurs prior to membrane fusion (4, 14). To
characterize fus-1/ic and to define the phenotype of the S1J
parent virus, we used MAb E1a-1 to compare the pH dependence of E1
conversion in wt SFV, fus-1, fus-1/ic, and S1J.
End point assays based on 10 min of virus pH treatment at 37°C were
performed. The exposure of the E1a-1 epitope for wt SFV had a
threshold of pH 6.2, while fus-1 and fus-1/ic
both had a shifted threshold of ~pH 5.0 (Fig.
1). The S1J pH threshold of 6.2 was
similar to that of wt SFV. The maximum extent of epitope exposure
for wt virus was about 40%, similar to published reports (4), while that of S1J was somewhat higher. E1 may not
completely convert due to the simultaneous acid inactivation of the
virus fusion activity (4). Both fus-1 and
fus-1/ic were inefficiently precipitated even at pH 4.8. Similar shifts in the fus-1 pH threshold were observed with
MAb anti-E1" (data not shown).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
pH dependence of E1 epitope exposure for wt and
mutant viruses. 35S-labeled wt/ic, S1J, fus-1,
and fus-1/ic virus preparations were treated at the
indicated pH for 10 min at 37°C, adjusted to neutral pH, solubilized
in lysis buffer containing 1% Triton X-100, and immunoprecipitated
with MAb E1a-1, an acid conformation-specific antibody. E1 precipitated
by the MAb was quantitated by SDS-PAGE and phosphorimaging and then
compared to the total E1 precipitated by a rabbit polyclonal antibody.
Data represent the mean of three separate experiments for each virus.
The standard deviations ranged from 1 to 30%.
|
|
A key intermediate in SFV fusion is the formation of an E1 homotrimer,
which occurs following treatment of wt virus at pH
6.2 or below
(
19,
35). The pH dependence of E1 homotrimer
formation for
wt SFV, S1J,
fus-1, and
fus-1/ic was determined
by pH treatment of
35S-labeled virus for 10 min at 37°C,
followed by mild SDS solubilization
to maintain the homotrimer and
SDS-PAGE analysis (Fig.
2). wt
SFV
homotrimer formation had a pH threshold of 6.2, whereas
fus-1 and
fus-1/ic homotrimer formation were
shifted to a pH threshold
of ~5.8. S1J homotrimer formation was
initiated at pH 6.2 but
displayed an intermediate pH dependence
compared to wt SFV and
fus-1. Similar results were obtained
in an alternative assay based
on the resistance of the E1 homotrimer to
trypsin digestion (data
not shown). Interestingly, the electrophoretic
migration of S1J,
fus-1, and
fus-1/ic homotrimers
on SDS-gels was slightly faster
than that of wt virus (data not shown).
As will be evident from
the sequence analysis below, this difference in
migration is unlikely
to be due to a change in E1's molecular weight
or posttranslational
processing and may suggest altered folding of the
E1 homotrimer
in S1J and
fus-1.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
pH dependence of wt and mutant E1 homotrimer formation.
35S-labeled wt/ic, S1J, fus-1, and
fus-1/ic virus preparations were treated at the indicated pH
for 10 min at 37°C in the presence of liposomes, adjusted to neutral
pH, and solubilized in SDS sample buffer for 3 min at 30°C. Samples
were analyzed by SDS-PAGE and quantitated by phosphorimaging. Results
are shown as percent E1 in the homotrimer band compared to total E1 and
represent the mean for three experiments, with standard deviations
between 1 and 33%.
|
|
In vivo virus entry phenotypes.
The sensitivity of virus
infection to NH4Cl, a weak base that neutralizes endosomal
acidity, correlates with the pH required to trigger viral membrane
fusion. The lower the pH threshold for fusion, the more sensitive virus
infection is to NH4Cl, as was clearly demonstrated for
fus-1 compared to the parental S1J virus (20). In
addition, resistance of virus infection to NH4Cl was previously used to select for fus-1 revertants, which were
demonstrated to have fusion properties similar to those of S1J
(21). We assayed the NH4Cl sensitivity of
fus-1/ic infection and compared it in parallel with that of
fus-1, wt SFV, S1J, and two fus-1 revertants, R43
and R46 (Fig. 3). Infection was
quantitated by measuring the ACD-insensitive incorporation of
[3H]uridine into viral RNA. Both fus-1 and
fus-1/ic were much more sensitive than wt SFV to
NH4Cl, displaying half-maximal inhibition at ~2.5 mM
NH4Cl compared to ~6.5 mM NH4Cl for wt SFV.
S1J, R43, and R46 were found to have similar NH4Cl
sensitivities as wt SFV, suggesting similar membrane fusion thresholds
that are significantly higher than that of fus-1. Taken
together, these results and the previous studies of S1J cell-cell
fusion (20) indicate that S1J has a membrane fusion
threshold resembling that of wt SFV, suggesting that the amount of
homotrimer generated by pH 6.2 treatment is sufficient to trigger S1J
fusion. In contrast, the substantially more acidic pH required for
fus-1 and fus-1/ic E1 conformational changes
leads to a significantly more acidic fusion threshold.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 3.
Sensitivity of infection by wt, mutant, and revertant
viruses to inhibition by NH4Cl. BHK cells were pretreated
with the indicated concentrations of NH4Cl for 15 min at
37°C and then infected with wt/ic, S1J, fus-1,
fus-1/ic, R43 revertant, or R46 revertant at 1 PFU/cell for
1.5 h in the continued presence of NH4Cl. Following
infection, the cells were treated with 2 µg of ACD per ml and 15 mM
NH4Cl for 30 min and then labeled with
[3H]uridine for 3.5 h in the continued presence of
ACD and 15 mM NH4Cl. Infection was quantitated as the
percent [3H]uridine incorporation compared to controls
infected in the absence of NH4Cl. Background incorporation
by uninfected cells was subtracted from all points. Data represent the
mean of three separate experiments for each virus, with standard
deviations between 1 and 20%.
|
|
Role of E1/E2 dimer dissociation in the fus-1
phenotype.
Following acid treatment, the first spike protein
conformational change detected is a weakening of the tight E1/E2
heterodimer interaction, resulting in the loss of both
coimmunoprecipitation and cosedimentation on sucrose gradients. For wt
virus, this conformational change has a threshold of ~pH 7.0 (33) and occurs with kinetics considerably faster than those
of E1 homotrimerization and conversion to MAb reactivity
(14). We tested the pH required to dissociate the
fus-1 dimer in order to determine if an altered dimer pH
threshold might be responsible for the acid-shifted phenotype of the E1 and E2 subunits. Coimmunoprecipitation assays were not successful, as
fus-1 was poorly recognized by our panel of anti-E2 and
anti-E1 MAbs (data not shown). We therefore used sucrose gradient
sedimentation analysis of pH-treated, NP-40-solubilized virus to
characterize the oligomeric structure of the E1 and E2 subunits of the
spike protein (6, 33). 35S-labeled wt or
fus-1 was pH treated for 10 min at 37°C, solubilized, neutralized, and analyzed by sedimentation on 5 to 20% sucrose gradients at pH 7.0. For wt SFV, the expected dimer and monomer peaks
were observed in pH 7.0-treated virus, while in virus exposed to pH 6.2 or 5.8, the dimer peak decreased, and a homotrimer peak was formed
(Fig. 4A). In contrast, fus-1
virus maintained clear dimer and monomer peaks even following treatment
as low as pH 5.6. Treatment at pH 5.3 or below was required to
completely dissociate the dimer peak and trigger the formation of a
homotrimer peak (Fig. 4B). While the wt virus showed considerable dimer
dissociation and homotrimer formation at pH 6.2, the fus-1
mutant showed almost no dimer dissociation and no homotrimer following
treatment at pH 6.2 (Fig. 4C). Aliquots of the peaks were analyzed by
SDS-PAGE, and in keeping with the published reports (34,
35), the results confirmed that the dimer peak contained E1 and
E2, while the monomer peak was primarily E2 and the homotrimer peak was
primarily E1 (data not shown).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Sucrose gradient sedimentation profiles of wt and
fus-1 viral spike proteins. 35S-labeled wt (A
and C) or fus-1 (B and C) virus was mixed with 1 mM
liposomes, treated at the indicated pH for 10 min at 37°C,
solubilized in 1.0 to 0.2% NP-40, and adjusted to pH 7.0. The samples
were analyzed by centrifugation on 5 to 20% (wt/wt) sucrose gradients
in buffer containing 0.1% NP-40. Gradients were centrifuged 22 h
at 4°C in an SW41 rotor at 39,000 rpm and fractionated, and
radioactivity was quantitated by scintillation counting. Fraction 1 represents the bottom of the gradient. The positions of the monomer
(m), dimer (d), and E1 homotrimer (h) peaks are indicated. Recoveries
ranged from 53 to 29%.
|
|
Radiolabeled virus prepared from the
fus-1/ic construct was
used to test if the phenotype of the cloned mutant was identical
to
that of
fus-1 virus (Fig.
5).
Similar to
fus-1,
fus-1/ic showed
a clear spike
protein dimer peak following treatment as low as
pH 5.6, and dimer
dissociation and homotrimer formation following
treatment at pH 5.3. Thus, these results indicate that dissociation
of the
fus-1
E1/E2 dimer is indeed significantly acid shifted.
Similar to the mild
acid shift of S1J homotrimer formation, the
pH dependence of S1J dimer
dissociation was also somewhat acid
shifted from that of wt SFV (data
not shown).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 5.
Sucrose gradient sedimentation profiles of
fus-1 and fus-1/ic viral spike proteins.
35S-labeled fus-1 or fus-1/ic virus
was mixed with 1 mM liposomes and treated at the indicated pH for
10 min at 37°C. Samples were solubilized, neutralized, and analyzed
by sucrose gradient sedimentation as for Fig. 4. Fraction 1 represents
the bottom of the gradient. The positions of the monomer (m), dimer
(d), and E1 homotrimer (h) peaks are indicated. Recoveries ranged from
32 to 63%.
|
|
If the pH shift in
fus-1 dimer dissociation is responsible
for the acid shift in its E1 conformational changes, then
predissociation
of the dimer should permit the
fus-1 E1
subunit to undergo conformational
changes with the same pH dependence
as that of wt E1. To assay
such a monomeric form of E1, we prepared the
E1 ectodomain fragment
of the protein, E1*. E1* is a soluble form of E1
in which the
protein transmembrane domain has been removed by
proteinase K
cleavage (
17). This form of E1 undergoes
similar acid-induced
conformational changes as the intact form of the
protein, including
epitope exposure and formation of a
trypsin-resistant homotrimer
(
17,
22). However, E1* is
monomeric and no longer associated
with E2 (
17,
22). The pH
dependence of wt E1* and that of
fus-1 E1* were compared by
measuring reactivity with an acid conformation-specific
MAb, and the
proteins were found to have identical pH thresholds
of ~pH 5.8 (Fig.
6A). The pH required to trigger E1*
homotrimer
formation was also determined for wt SFV and
fus-1 and found to
be ~5.8 for both proteins (Fig.
6B).
These data indicate that
as a monomer not associated with the E2
subunit,
fus-1 E1* can
undergo its pH-dependent
conformational changes with the same
pH threshold as wt SFV E1* and
support the conclusion that the
fus-1 defect involves a pH
shift in the dissociation of the E1/E2
dimer.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 6.
pH dependence of E1* conformational changes. (A)
Reactivity with MAb E1a-1. 35S-labeled wt and
fus-1 ectodomains were treated at the indicated pH for 10 min at 37°C in the presence of 1 mM liposomes, adjusted to neutral
pH, solubilized in lysis buffer containing 1% Triton X-100, and
immunoprecipitated with MAb E1a-1. E1* precipitation was quantitated by
SDS-PAGE and phosphorimaging and compared to total E1* precipitated by
a rabbit polyclonal antibody. Data represent the mean of three separate
experiments. (B) E1* homotrimer formation.
35S-labeled wt SFV and fus-1 ectodomains were
treated at the indicated pH for 10 min at 37°C in the presence of
liposomes, adjusted to neutral pH, and solubilized in SDS sample buffer
for 3 min at 30°C. E1 homotrimer formation was quantitated by
SDS-PAGE and phosphorimaging. Data represent means of three separate
experiments.
|
|
Determination of the mutation responsible for the fus-1
phenotype.
As described above, the infectious clone encoding the
fus-1 structural proteins reproduced the fus-1
phenotype in all assays, indicating that the mutation(s) responsible
for the fus-1 defect was contained within the subcloned
NdeI-BglII fragment. The sequence of this
fragment in fus-1/ic was compared to that of wt/ic (obtained from Peter Liljeström). Six amino acid changes were observed. All
changes in fus-1/ic were confirmed to be present in the
fus-1 virus stock by reverse transcription of RNA from
fus-1 virus-PCR amplification (RT-PCR) and sequencing of
selected regions. The sequences at these positions in wt/ic and in our
wt virus stock were confirmed by sequence analysis of the clone or
RT-PCR and sequencing of virus RNA.
Figure
7 lists the amino acid sequence
differences found between the
fus-1/ic and
fus-1
virus sequences and the wt/ic and
wt virus sequences. The
fus-1 E3 and 6K sequences were found to
be identical to the
wt sequence. The
fus-1 capsid sequence contained
two
amino acid changes, glutamine 80 to proline (CAG

CCG) and
asparagine
85 to lysine (AAC

AAA). Three changes, threonine 12
to
isoleucine (ACA

ATA), lysine 162 to glutamate (AAG

GAG), and
histidine 170 to arginine (CAT

CGT), were observed in E2. One
change,
aspartic acid 323 to alanine (GAC

GCC), occurred in E1.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 7.
Amino acid sequence differences among wt, mutant, and
revertant virus structural proteins. The E2 isoleucine 12 change
responsible for the fus-1 phenotype is marked (*). No
amino acid sequence differences were observed between wt/ic and wt SFV
or between fus-1 and fus-1/ic. The positions of
the SFV structural protein coding regions are marked.
|
|
Since
fus-1 was derived from S1J, some of the six amino acid
changes could be due to its genetic background. Although S1J
and
wt SFV came from the same original SFV isolate and have similar
passage histories, the two wt stocks are different
plaque-purified
isolates (
20,
31). Partial
sequence analysis of S1J had previously
revealed two amino
acid differences from the published wt SFV
sequence, E1 D323

A, and
E2 H170

R (
31). Therefore, these two
amino acid
changes detected in
fus-1 were due to its S1J
background.
RT-PCR and sequence analysis of S1J RNA were performed, and
the
results demonstrated that all of the
fus-1/ic amino acid
alterations
were due to background changes in the parental S1J virus,
with
the single exception of E2 T12

I (Fig.
7). This result suggested
that the
fus-1 pH shift phenotype was due to the
substitution
of isoleucine at E2 position 12, a position that is
threonine
in both wt SFV and S1J.
To confirm that the E2 T12

I amino acid change was in fact the
specific mutation responsible for the
fus-1 phenotype, we
analyzed
the sequences of two
fus-1 revertants, R43 and R46,
in the regions
containing the six amino acid changes from wt SFV (Fig.
7). The
sequence of R43 was identical to that of the S1J parent and had
reverted to threonine at E2 position 12. The sequence of R46 was
identical to S1J at all six positions, including E2 T12, but in
addition contained an extra mutation of alanine to serine at E2
position 70. This mutation presumably does not affect the R46
fusion
phenotype, as its membrane fusion and NH
4Cl sensitivity
were identical to those of S1J, R43, and wt SFV (Fig.
3 and
reference
21). Thus,
fus-1 contains a
critical amino acid change, E2 I12,
which reverts to the parental T12
in two
fus-1 revertants, identifying
E2 I12 as the genetic
alteration producing the acid-shifted fusion
phenotype of
fus-1.
 |
DISCUSSION |
The SFV mutant fus-1 has been used in cell biological
studies as a probe for the pH of compartments of the endocytic pathway (20, 21, 29). The mutant was also important in establishing the correlation between the pH threshold of SFV fusion and the sensitivity of virus infection to various concentrations of weak bases,
ionophores, or specific inhibitors of the vacuolar proton pump such as
bafilomycin (10, 20). The finding that an SFV mutant with a
lower pH threshold for in vitro fusion also has a lower pH threshold
for spike protein conformational changes and a higher sensitivity to
agents that neutralize endosomal acidity provided strong evidence for
the key role of low pH in triggering fusion during SFV infection. In
spite of its use in such cell biology and virology systems, however,
the genetic alteration in fus-1 was unknown, and its
phenotype of lower pH thresholds for the conformational changes in both
the E1 and E2 subunits was puzzling. Recent studies demonstrated that
mL, an engineered virus with a p62 cleavage mutation, had a more acidic
pH threshold for virus fusion and E1 conformational changes, due to a
more acidic pH threshold for dimer dissociation (28). The
similarities in the phenotypes of fus-1 and mL suggested
that the fus-1 mutation could be acting to shift the pH of
dimer dissociation. Kinetic studies of wt dimer dissociation indicate
that it occurs prior to E1 epitope exposure and homotrimer
formation, in keeping with its possible role in regulating these
conformational changes (14). Our results revealed that the
fus-1 E1 conformational changes all had a more acidic pH
threshold than wt and that the dissociation of the fus-1
E1/E2 dimer was also shifted to a more acidic pH. In contrast,
monomeric E1* from fus-1 had the same pH threshold as wt E1*
for MAb reactivity and homotrimer formation, indicating that the pH
shift in E1 conformational changes was lost once the fus-1
E1/E2 dimer interaction was disrupted. Sequence analysis of
fus-1 and two fus-1 revertants demonstrated that
the relevant amino acid alteration in fus-1 was a change of
E2 T12
I. Thus, the substitution of isoleucine on E2 acted to
stabilize the dimer interaction between the fus-1 E1 and E2
subunits and regulated the pH dependence of E1-catalyzed fusion.
In addition to the T12
I change, fus-1 has five other
changes from our wt SFV strain, all of which are background changes found in its parent strain, S1J. S1J is similar to our plaque-purified wt strain in the pH dependence of cell-cell fusion, NH4Cl
sensitivity, E1 MAb reactivity, and E1 homotrimer formation (this study
and reference 20). In previous in vivo studies, we
characterized wt, fus-1, and revertant RNA release into the
cytoplasm following fusion in the endosome (21). Since
endosomes become more acidic with time (27), viruses with a
lower pH threshold of fusion do not fuse until later in the endocytic
pathway and show a slower release of virus RNA. The half-time of wt RNA
penetration was ~15 min, and that of fus-1 was ~45 min.
The half-time of revertant RNA penetration was ~25 min. This
difference in the kinetics of RNA release between wt and revertants may
reflect S1J background differences, which merit further investigation.
In previous unpublished experiments, the cDNA encoding the
fus-1 structural proteins was expressed transiently in COS
cells via a simian virus 40 vector. Surprisingly, although this system faithfully reproduces the phenotype of other SFV fusion mutants (13, 19, 23), the fus-1 spike protein did not
exhibit an acid-shifted pH threshold for COS cell fusion. This same
cDNA showed a markedly acid-shifted fusion threshold when here
expressed in the context of the SFV infectious clone. These results
could be due to technical limitations of the syncytium assay, which can
be affected by such variables as spike protein density (36). Alternatively, a requirement for the nucleocapsid or assembled virus
particle may be necessary for expression of the fus-1
phenotype.
The alphavirus structural proteins are ~51% identical in the E1
subunit and ~42% identical in the E2 subunit, and they show striking
conservation of residues such as cysteine and proline that are of
particular importance in conferring secondary structure, suggesting
overall conservation of spike structure (30). The fus-1 T12
I substitution occurs close to the p62 cleavage
site within the amino-terminal domain of E2 and is predicted to cause an increase in the hydrophobicity of this region and the loss of
the hydrogen bonding capability of threonine. Figure
8 shows the amino acid sequences of
several different alphaviruses in the E2 T12 region. The region
contains invariant proline at position 14, tyrosine at position 15, and
cysteine residues at 19 and 22. Seven of ten alphaviruses contain
threonine at position 12, while eastern and western equine encephalitis
viruses contain alanine at position 12. Interestingly, like
fus-1, Chickungunya virus has isoleucine at position 12. The
fusion pH threshold for this alphavirus is not known.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 8.
Sequence comparison of the E2 T12 region in
alphaviruses. Amino acid numbering is given for SFV E2, starting with
residue 1 at the amino terminus. The tetrabasic cleavage site which
generates E3 and E2 is boxed, invariant residues in E2 are shown in
bold, and sequence gaps are shown as dashes. The sequence of this
region of fus-1 is identical to that of wt SFV except for
the T12 I change. RRV, Ross River virus; CHICK (Chickungunya virus)
(NCBI accession no. 576465); EEV, eastern equine encephalitis virus;
OMN, O'Nyong-nyong virus; VEE, Venezuelan equine encephalitis virus;
WEE, western equine encephalitis virus; SV, Sindbis virus; AURA, Aura
virus; OCK, Ockelbo virus, as listed in references
16 and 30.
|
|
Our results indicate that isoleucine at the E2 12 position leads to
increased stability of the E1/E2 dimer. Additional examples of a
potential role for isoleucine in the stabilization of
protein-protein interactions are suggested by analysis of
influenza virus hemagglutinin (HA) mutants selected for a higher pH
threshold of fusion. HA is a trimer containing three copies of
HA1, the receptor binding domain, and HA2,
which makes up the stem region and contains the transmembrane domain
and N-terminal fusion peptide (see references 12 and
37 for reviews). HA mutants that fuse at higher
pH fall into two classes. One group contains mutants that map
within or close to the fusion peptide and act to destabilize its
normally buried position in the HA trimer. Among such destabilizing
mutants is a change of the wt isoleucine at HA2 6, within
the fusion peptide, to methionine. The second class of fusion
mutants localizes to residues in the trimer interface that stabilize
inter-HA interactions. A mutant at position HA2
81 changes a wt isoleucine to serine, resulting in a less stable HA
trimer and a higher fusion threshold. Thus, these two examples in a
pH-dependent fusion protein with well-characterized structure suggest
that the presence of an isoleucine may act to stabilize subunit
interactions, similar to our model for the effect of the
fus-1 mutation.
The currently available information suggests that several different
types of mutations can affect the pH threshold of alphavirus fusion via
different mechanisms. As discussed here, the fus-1 mutation
and mutations that prevent p62 cleavage decrease the fusion pH
threshold by increasing the stability of the E1/E2 dimer interaction.
Mutations within the putative E1 fusion peptide can also cause a more
acidic pH threshold for fusion (19, 23). In contrast to
fus-1, such fusion peptide mutants have an E1/E2 dimer
interaction less stable than that of wt virus but have a marked
decrease in the pH threshold and efficiency with which E1 subsequently
trimerizes and associates with the target membrane (19). A
Sindbis virus neurovirulence mutant has two mutations in different
regions within the E1 subunit, valine 72
alanine and glycine
313
aspartate, which cause a more acidic fusion threshold by an
unknown mechanism (3). Taken together, results from these alphavirus fusion mutants suggest that various domains of the spike
protein are involved in the overall control of the protein's response
to acid pH and that these domains play different roles in the fusion
reaction. Our results with fus-1 identify a domain of the
SFV E2 spike subunit that controls fusion pH dependence and indicate
that a mutation in this region acts indirectly on E1 by its effect on
the dimer stability.
 |
ACKNOWLEDGMENTS |
We thank Matthew Klimjack and Anna Ahn for technical assistance,
the members of our laboratory for helpful discussions and suggestions,
and Duncan Wilson and the members of our laboratory for critical
reading of the manuscript. We thank Jack Lenz for very helpful advice
on the use of the revertants, and we thank Peter Liljeström and
Henrik Garoff for providing pSP6-SFV4.
This work was supported by grants to M.K. from the Public Health
Service (GM52929) and the Hirschl Charitable Trust, by a Jack K. and
Helen B. Lazar fellowship in cell biology, and by Cancer Center core
support grant NIH/NCI P30-CA13330. S.G.-R. was supported by NIH
training grant 2T32 CA09173-15.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park
Ave., Bronx, NY 10461. Phone: (718) 430-3638. Fax: (718) 430-8574. E-mail: kielian{at}aecom.yu.edu.
 |
REFERENCES |
| 1.
|
Bentz, J.
1993.
In
Viral fusion mechanisms, p. 1-529.
CRC Press, Boca Raton, Fla.
|
| 2.
|
Binley, J., and J. P. Moore.
1997.
HIV-cell fusion: the viral mousetrap.
Nature
387:346-348[Medline].
|
| 3.
|
Boggs, W. M.,
C. S. Hahn,
E. G. Strauss,
J. H. Strauss, and D. E. Griffin.
1989.
Low pH-dependent Sindbis virus-induced fusion of BHK cells: differences between strains correlate with amino acid changes in the E1 glycoprotein.
Virology
169:485-488[Medline].
|
| 4.
|
Bron, R.,
J. M. Wahlberg,
H. Garoff, and J. Wilschut.
1993.
Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein.
EMBO J.
12:693-701[Medline].
|
| 5.
|
deCurtis, I., and K. Simons.
1988.
Dissection of Semliki Forest virus glycoprotein delivery from the trans-Golgi network to the cell surface in permeabilized BHK cells.
Proc. Natl. Acad. Sci. USA
85:8052-8056[Abstract/Free Full Text].
|
| 6.
|
Duffus, W. A.,
P. Levy-Mintz,
M. R. Klimjack, and M. Kielian.
1995.
Mutations in the putative fusion peptide of Semliki Forest virus affect spike protein oligomerization and virus assembly.
J. Virol.
69:2471-2479[Abstract].
|
| 7.
|
Feng, Y.,
C. C. Broder,
P. E. Kennedy, and E. A. Berger.
1996.
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
Science
272:872-877[Abstract].
|
| 8.
|
Garoff, H.,
A.-M. Frischauf,
K. Simons,
H. Lehrach, and H. Delius.
1980.
Nucleotide sequence of cDNA coding for Semliki Forest virus membrane glycoproteins.
Nature
288:236-241[Medline].
|
| 9.
|
Garoff, H.,
J. Wilschut,
P. Liljestrom,
J. M. Wahlberg,
R. Bron,
M. Suomalainen,
J. Smyth,
A. Salminen,
B. U. Barth, and H. Zhao.
1994.
Assembly and entry mechanisms of Semliki Forest virus.
Arch. Virol.
9:329-338.
|
| 10.
| Glomb-Reinmund, S., and M. Kielian. 1998. Unpublished data.
|
| 11.
|
Hernandez, L. D.,
L. R. Hoffman,
T. G. Wolfsberg, and J. M. White.
1996.
Virus-cell and cell-cell fusion.
Annu. Rev. Cell Dev. Biol.
12:627-661.
[Medline] |
| 12.
|
Hughson, F. M.
1995.
Structural characterization of viral fusion proteins.
Curr. Biol.
5:265-274[Medline].
|
| 13.
|
Jain, S. K.,
S. DeCandido, and M. Kielian.
1991.
Processing of the p62 envelope precursor protein of Semliki Forest virus.
J. Biol. Chem.
266:5756-5761[Abstract/Free Full Text].
|
| 14.
|
Justman, J.,
M. R. Klimjack, and M. Kielian.
1993.
Role of spike protein conformational changes in fusion of Semliki Forest virus.
J. Virol.
67:7597-7607[Abstract/Free Full Text].
|
| 15.
|
Keränen, S., and L. Kääriäinen.
1974.
Isolation and basic characterization of temperature-sensitivity mutants from Semliki Forest virus.
Acta Pathol. Microbiol. Scand. Sect. B
82:810-820.
|
| 16.
|
Kielian, M.
1995.
Membrane fusion and the alphavirus life cycle.
Adv. Virus Res.
45:113-151[Medline].
|
| 17.
|
Kielian, M., and A. Helenius.
1985.
pH-induced alterations in the fusogenic spike protein of Semliki Forest virus.
J. Cell Biol.
101:2284-2291[Abstract/Free Full Text].
|
| 18.
|
Kielian, M.,
S. Jungerwirth,
K. U. Sayad, and S. DeCandido.
1990.
Biosynthesis, maturation, and acid activation of the Semliki Forest virus fusion protein.
J. Virol.
64:4614-4624[Abstract/Free Full Text].
|
| 19.
|
Kielian, M.,
M. R. Klimjack,
S. Ghosh, and W. A. Duffus.
1996.
Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus.
J. Cell Biol.
134:863-872[Abstract/Free Full Text].
|
| 20.
|
Kielian, M. C.,
S. Keränen,
L. Kääriäinen, and A. Helenius.
1984.
Membrane fusion mutants of Semliki Forest virus.
J. Cell Biol.
98:139-145[Abstract/Free Full Text].
|
| 21.
|
Kielian, M. C.,
M. Marsh, and A. Helenius.
1986.
Kinetics of endosome acidification detected by mutant and wild-type Semliki Forest virus.
EMBO J.
5:3103-3109[Medline].
|
| 22.
|
Klimjack, M. R.,
S. Jeffrey, and M. Kielian.
1994.
Membrane and protein interactions of a soluble form of the Semliki Forest virus fusion protein.
J. Virol.
68:6940-6946[Abstract/Free Full Text].
|
| 23.
|
Levy-Mintz, P., and M. Kielian.
1991.
Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein.
J. Virol.
65:4292-4300[Abstract/Free Full Text].
|
| 24.
|
Liljeström, P.,
S. Lusa,
D. Huylebroeck, and H. Garoff.
1991.
In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release.
J. Virol.
65:4107-4113[Abstract/Free Full Text].
|
| 25.
|
Lobigs, M., and H. Garoff.
1990.
Fusion function of the Semliki Forest virus spike is activated by proteolytic cleavage of the envelope glycoprotein precursor p62.
J. Virol.
64:1233-1240[Abstract/Free Full Text].
|
| 26.
|
Lobigs, M.,
J. M. Wahlberg, and H. Garoff.
1990.
Spike protein oligomerization control of Semliki Forest virus fusion.
J. Virol.
64:5214-5218[Abstract/Free Full Text].
|
| 27.
|
Mellman, I.,
R. Fuchs, and A. Helenius.
1986.
Acidification of the endocytic and exocytic pathways.
Annu. Rev. Biochem.
55:663-700[Medline].
|
| 28.
|
Salminen, A.,
J. M. Wahlberg,
M. Lobigs,
P. Liljeström, and H. Garoff.
1992.
Membrane fusion process of Semliki Forest virus II: cleavage-dependent reorganization of the spike protein complex controls virus entry.
J. Cell Biol.
116:349-357[Abstract/Free Full Text].
|
| 29.
|
Schmid, S. L.,
R. Fuchs,
M. Kielian,
A. Helenius, and I. Mellman.
1989.
Acidification of endosome subpopulations in wild-type Chinese hamster ovary cells and temperature-sensitive acidification-defective mutants.
J. Cell Biol.
108:1291-1300[Abstract/Free Full Text].
|
| 30.
|
Strauss, J. H., and E. G. Strauss.
1994.
The alphaviruses: gene expression, replication, and evolution.
Microbiol. Rev.
58:491-562[Abstract/Free Full Text].
|
| 31.
|
Syvaoja, P.,
J. Peranen,
M. Suomalainen,
S. Keränen, and L. Kääriäinen.
1990.
A single amino acid change in E3 of ts1 mutant inhibits the intracellular transport of SFV envelope protein complex.
Virology
179:658-666[Medline].
|
| 32.
|
Vashishtha, M.,
T. Phalen,
M. T. Marquardt,
J. S. Ryu,
A. Ng, and M. Kielian.
1998.
A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit.
J. Cell Biol.
140:91-99[Abstract/Free Full Text].
|
| 33.
|
Wahlberg, J. M.,
W. A. M. Boere, and H. Garoff.
1989.
The heterodimeric association between the membrane proteins of Semliki Forest virus changes its sensitivity to low pH during virus maturation.
J. Virol.
63:4991-4997[Abstract/Free Full Text].
|
| 34.
|
Wahlberg, J. M.,
R. Bron,
J. Wilschut, and H. Garoff.
1992.
Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein.
J. Virol.
66:7309-7318[Abstract/Free Full Text].
|
| 35.
|
Wahlberg, J. M., and H. Garoff.
1992.
Membrane fusion process of Semliki Forest virus I: low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells.
J. Cell Biol.
116:339-348[Abstract/Free Full Text].
|
| 36.
|
White, J. M.
1990.
Viral and cellular membrane fusion proteins.
Annu. Rev. Phys.
52:675-697.
[Medline] |
| 37.
|
Wiley, D. C., and J. J. Skehel.
1987.
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.
Annu. Rev. Biochem.
56:365-394[Medline].
|
J Virol, May 1998, p. 4281-4287, Vol. 72, No. 5
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Qin, Z.-l., Zheng, Y., Kielian, M.
(2009). Role of Conserved Histidine Residues in the Low-pH Dependence of the Semliki Forest Virus Fusion Protein. J. Virol.
83: 4670-4677
[Abstract]
[Full Text]
-
Wu, S.-R., Haag, L., Sjoberg, M., Garoff, H., Hammar, L.
(2008). The Dynamic Envelope of a Fusion Class II Virus: E3 DOMAIN OF GLYCOPROTEIN E2 PRECURSOR IN SEMLIKI FOREST VIRUS PROVIDES A UNIQUE CONTACT WITH THE FUSION PROTEIN E1. J. Biol. Chem.
283: 26452-26460
[Abstract]
[Full Text]
-
Taylor, G. M., Hanson, P. I., Kielian, M.
(2007). Ubiquitin Depletion and Dominant-Negative VPS4 Inhibit Rhabdovirus Budding without Affecting Alphavirus Budding. J. Virol.
81: 13631-13639
[Abstract]
[Full Text]
-
Liao, M., Kielian, M.
(2006). Functions of the Stem Region of the Semliki Forest Virus Fusion Protein during Virus Fusion and Assembly. J. Virol.
80: 11362-11369
[Abstract]
[Full Text]
-
Liao, M., Kielian, M.
(2006). Site-Directed Antibodies against the Stem Region Reveal Low pH-Induced Conformational Changes of the Semliki Forest Virus Fusion Protein. J. Virol.
80: 9599-9607
[Abstract]
[Full Text]
-
Zhang, X., Fugere, M., Day, R., Kielian, M.
(2003). Furin Processing and Proteolytic Activation of Semliki Forest Virus. J. Virol.
77: 2981-2989
[Abstract]
[Full Text]
-
Hammar, L., Markarian, S., Haag, L., Lankinen, H., Salmi, A., Cheng, R. H.
(2003). Prefusion Rearrangements Resulting in Fusion Peptide Exposure in Semliki Forest Virus. J. Biol. Chem.
278: 7189-7198
[Abstract]
[Full Text]
-
Lee, P., Knight, R., Smit, J. M., Wilschut, J., Griffin, D. E.
(2002). A Single Mutation in the E2 Glycoprotein Important for Neurovirulence Influences Binding of Sindbis Virus to Neuroblastoma Cells. J. Virol.
76: 6302-6310
[Abstract]
[Full Text]
-
Gibbons, D. L., Kielian, M.
(2002). Molecular Dissection of the Semliki Forest Virus Homotrimer Reveals Two Functionally Distinct Regions of the Fusion Protein. J. Virol.
76: 1194-1205
[Abstract]
[Full Text]
-
Lu, Y. E., Eng, C. H., Shome, S. G., Kielian, M.
(2001). In Vivo Generation and Characterization of a Soluble Form of the Semliki Forest Virus Fusion Protein. J. Virol.
75: 8329-8339
[Abstract]
[Full Text]
-
Lu, Y. E., Kielian, M.
(2000). Semliki Forest Virus Budding: Assay, Mechanisms, and Cholesterol Requirement. J. Virol.
74: 7708-7719
[Abstract]
[Full Text]
-
Gibbons, D. L., Ahn, A., Chatterjee, P. K., Kielian, M.
(2000). Formation and Characterization of the Trimeric Form of the Fusion Protein of Semliki Forest Virus. J. Virol.
74: 7772-7780
[Abstract]
[Full Text]
-
Chatterjee, P. K., Vashishtha, M., Kielian, M.
(2000). Biochemical Consequences of a Mutation That Controls the Cholesterol Dependence of Semliki Forest Virus Fusion. J. Virol.
74: 1623-1631
[Abstract]
[Full Text]
-
Ahn, A., Klimjack, M. R., Chatterjee, P. K., Kielian, M.
(1999). An Epitope of the Semliki Forest Virus Fusion Protein Exposed during Virus-Membrane Fusion. J. Virol.
73: 10029-10039
[Abstract]
[Full Text]